Americans still don't meet guideline-recommended physical activity levels even while sedentary behavior increases, according to a new NHANES analysis.
Study: "Ideal" adherence to healhty habits (eg, weight control, no smoking, average A1c) may reduce risk of heart failure by >50% vs "inadequate" adherence.
US consumption of red meat remains twice the global average. New research highlights the consequences of that intake in terms of all-cause mortality.
Saturated fat and cholesterol from red meat have long been known to be bad for heart health, but recent research sheds light on a possible new culprit.
In this older patient with T2DM, HFpEF, and other comorbidities, which class of medication is most appropriate--and guideline-recommended?
The new "sweet spot" in diabetes management is the interdisciplinary approach that is essential to treating all aspects of the disease. New diabetes medications also hit that spot.
ADA 2019--Linagliptin, the DPP-4 inhibitor, showed similar risk for first or recurrent CV events or hopspitalization vs placebo in T2DM patients with high cardiorenal risk in CARMELINA subanalysis.
ADA 2019—Dapagliflozin reduced CV death, hospitalization for HF, and progression of CKD among T2DM patients with a wide distribution of baselines CVD risk in DECLARE-TIMI 58.
Daily aspirin for primary prevention of heart disease is a practice under scrutiny. Based on the new 2019 ACC/AHA CVD prevention guidelines, is this patient a candidate?
Test your knowledge of the key elements and outcomes of the highly buzzed about REDUCE-IT trial with this 5-question quiz.